American Herbal Products Association (AHPA) > About Us > Committees > Government Relations Committee

Government Relations Committee

Chairperson: Staci Eisner (Cortex Scientific)
Staff Contact: Michael McGuffin

Committee Purpose: To monitor legislative and regulatory issues and agencies for the purpose of developing industry positions that conform to AHPA's mission.

AHPA Members, if you would like to join this committee, please email the staff contact.

 

Committee Meeting Minutes and News

Arizona Board of Pharmacy reportedly considers most dietary supplements to be nonprescription drugs

Board is pushing supplement companies that sell in the state to register as "wholesaler of nonprescription drugs"

The Arizona State Board of Pharmacy recently began interpreting its authority in a manner that implies that virtually every company that manufacturers or sells dietary supplements in the state will need to register as a nonprescription drug facility. If the board is successful and persistent in this approach, it could significantly disrupt dietary supplement business in the state.

AHPA requests pullulan be allowed in dietary supplement products labeled as organic

AHPA supports petition submitted by the Organic Trade Association (OTA) to request that pullulan be added to the National List

The American Herbal Products Association (AHPA) submitted comments yesterday to the National Organic Standards Board (NOSB) to request that pullulan continue to be allowed to be used in encapsulated herbs marketed as “made with organic [specified ingredients or food group(s)]” under the National Organic Program (NOP).

AHPA advocates for inclusion of the Hemp Production amendment in the 2018 Farm Bill

AHPA encourages Senate and House conferees to remove unnecessary restriction in conference

AHPA strongly supports inclusion of the provisions of the Hemp Farming Act of 2018 in the Farm Bill, as included in the version passed by the Senate on June 28, 2018, and notes that similar language is not included in the House version of this legislation (H.R. 2).
AHPA submits GMO labeling recommendations to USDA

AHPA submits GMO labeling recommendations to USDA

USDA proposal would hinder consumer access to information on genetically modified foods

In an effort to ensure American consumers can discern if their food includes GMOs, AHPA recommended significant revisions to a proposed rule issued by USDA's Agricultural Marketing Service (AMS) to establish a mandatory, national bioengineered (BE) food disclosure standard.

AHPA endorses the Hemp Farming Act of 2018

AHPA Board adopts policy to support any state or federal efforts to decriminalize hemp

AHPA is endorsing federal legislation recently introduced to decriminalize hemp and the AHPA Board of Trustees has adopted a policy for the association to support any future state or federal legislation to decriminalize the plant and all its derivatives.

AHPA meetings and events at Natural Products Expo West

AHPA Annual Member meeting, reception, awards, committee meetings and more!

March 5-8, 2018 -- Anaheim Convention Center, California

AHPA recommends regulatory improvements in comments submitted to CFSAN

Recommendations seek to reduce regulatory burdens while maintaining consumer protections

The American Herbal Products Association (AHPA) submitted nearly 100 pages of comments today to the Food and Drug Administration (FDA) Center for Food Safety and Applied Nutrition (CFSAN) identifying numerous ways to improve regulations, guidance documents, and enforcement practices to protect public health more effectively and efficiently.
McGuffin statement on Sen. Hatch retirement

McGuffin statement on Sen. Hatch retirement

DSHEA was a remarkable achievement, made possible in large part by Sen. Hatch’s persistence and hard work

American Herbal Products Association (AHPA) President Michael McGuffin issued the following statement regarding the retirement of Sen. Orrin Hatch (R-UT), a vocal dietary supplement advocate who helped shape the laws that regulate the industry.
Industry Coalition Reminds Consumers, Retailers, and Product Marketers that Dietary Supplements Cannot Claim to Treat Opioid Addiction

Industry Coalition Reminds Consumers, Retailers, and Product Marketers that Dietary Supplements Cannot Claim to Treat Opioid Addiction

Industry trade associations have been consistent in taking strong positions against marketing dietary supplements for treatment or prevention of diseases

The dietary supplement industry is aware of growing concerns regarding significant negative health impacts associated with opioid addiction and abuse. The leading trade associations of the dietary supplement industry support the responsible marketing and use of health-promoting vitamins, minerals, herbs, sports nutrition, and other dietary supplements.

AHPA submits comments on pre-DSHEA dietary ingredient list

AHPA recommended that FDA make significant changes to previous positions on new dietary ingredients (NDIs)

AHPA's comments were submitted in response to FDA's request for input on issues related to the future development of a list of dietary ingredients marketed in the United States prior to October 15, 1994, when the Dietary Supplement Health and Education Act (DSHEA) became law.
RSS
1234